<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03053336</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr: 2016/2041-31/2</org_study_id>
    <nct_id>NCT03053336</nct_id>
  </id_info>
  <brief_title>App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes</brief_title>
  <official_title>App-technology to Enhance Self-care for Patients With Diabetes Type 2 - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of using new app-based technology to
      improve self-care, compared to usual care in patients with type 2 diabetes. The hypothesis is
      that the intervention, i.e. using the new technology, will have a greater positive effect on
      physical activity levels and outcomes of HbA1c than usual care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in physical activity level (counts/min from accelerometers)</measure>
    <time_frame>baseline and month 3, 6 and 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c (mmol/mol)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Steps/day</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol (mmol/L)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL-cholesterol (mmol/L)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides (mmol/L)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein A1 (g/l)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein B (g/l)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight (kg)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI, kg/m2)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
    <description>Including: %Body Fat, Fat free mass (kg), Muscle mass (kg), Total body water (kg, %)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference (cm)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (mmHg)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in dietary habits assessed using a food frequency questionnaire</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in tobacco use habits (smoking and Swedish snuff use)</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in sleeping habits assessed using a 13 item questionnaire</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in perceived purpose in life</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in perceived stress levels using the perceived stress scale</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in reported self-efficacy for exercise</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
    <description>One's confidence in walking is assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in reported self-efficacy diabetes is assessed using a 20 item questionnaire</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in RAND-36</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in neighborhood Environment assessed by questions on safety and walking environment</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Social support for exercise assessed using a 6 item questionnaire</measure>
    <time_frame>Baseline and month 3, 6 and 12</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>App-technology group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the intervention group (App-technology) will use a newly developed smartphone application (&quot;app&quot;) in which steps are automatically measured and laboratory values from blood sampling within primary care will be shown.
Intervention: App-technology to increase physical activity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will receive standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>App-technology to increase physical activity</intervention_name>
    <description>Access to the smartphone-app during 12 weeks. A personal step goal is set for each individual in the app.</description>
    <arm_group_label>App-technology group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a diagnosis of type 2 diabetes

          -  18 years of age or older

          -  Ability to communicate in Swedish

          -  Have and be able to use a smartphone

        Exclusion Criteria:

          -  Not being able to walk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ylva Trolle Lagerros, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet and Stockholm County Councill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ylva Trolle Lagerros, MD, PhD</last_name>
    <phone>0046851779183</phone>
    <email>ylva.trolle@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephanie E Bonn, PhD</last_name>
    <phone>0046851779173</phone>
    <email>stephanie.bonn@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska Institutet</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ylva Trolle Lagerros, MD, PhD</last_name>
      <phone>0046851779183</phone>
      <email>ylva.trolle@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2017</study_first_submitted>
  <study_first_submitted_qc>February 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2017</study_first_posted>
  <last_update_submitted>August 16, 2017</last_update_submitted>
  <last_update_submitted_qc>August 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Ylva Trolle Lagerros</investigator_full_name>
    <investigator_title>MD, Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

